Press release
Depression Drugs Market is Growing at CAGR of 4% to Achieve US$ 20 Billion by 2031 | Fact.MR
The depression medications market, which was estimated to be worth over US$ 6.5 billion in 2017, is expected to see bearishness soon. A recent Fact.MR analysis estimated that revenues would drop at a CAGR of -2%. The study indicates that even if the incidence of depression prevalence has increased over the past ten years, there has been a decrease in the demand for depression medications due to people's choice for cognitive behavior therapy (CBT) and their understanding of its possible negative effects. According to the report, the US led the world in the overall amount of depression medications marketed in 2018.The World Health Organization (WHO) estimates that over 300 million people worldwide suffer from depression, making it one of the most prevalent illnesses. The National Institute of Mental Health (NIMH) estimates that 10.3 million adults in the US had at least one major depressive episode that caused substantial impairment. Adults between the ages of 18 and 25 had the highest frequency of such depressive episodes (10.9%), followed by female adults (8.5%) and male adults (4.8%). As to the Fact.MR survey, while depression remains a significant health concern, patients and the medical community are advocating for a non-pharmaceutical approach to minimize adverse effects and dependence. In order to promote long-term management of depression and other mental health conditions, healthcare professionals and patients are putting a greater emphasis on mindfulness-based techniques and cognitive behavior therapy (CBT).
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=3215
Popularity of Tech-based Mental Health Apps Also Contributing to Low Sales
According to the study, as end users have more coping mechanisms available to them, the market for depression medications is likewise seeing a downturn. The enormous success of mental health applications like SuperBetter, Moodnotes, Headspace, Calm, and Pacifica has offered patients greater autonomy over their depression management. In light of the increasing amount of studies indicating benefits for both meditation and cognitive behavior therapy, the number of apps on the market has increased recently. According to the report, these developments will have an ongoing impact on the market for depression medications.
Depression Drugs Market to Remain Concentrated in Developed Nations
Due to a concentration of major market competitors and increased research and development of these treatments, North America and Europe account for the two largest global markets for depression drugs. The Asia Pacific region's market for depression drugs is predicted to expand negatively due to a lack of widespread understanding of antidepressant medications (ADMs), despite the fact that mental illnesses including schizophrenia and bipolar I disorder are becoming more common in China and India. Furthermore, alternative depression treatments have longer-lasting effects and are just as effective as ADM, which could impede the market's future growth for depression medications, particularly in Asia Pacific and the Middle East and Africa.
๐๐๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ซ ๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ: https://www.factmr.com/connectus/sample?flag=RC&rep_id=3215
Depression Drugs Market: Segment-wise Insights
The global market for depression pharmaceuticals has been divided into several segments based on the type of drug used, including SSRIs, atypical antipsychotics, SNRIs, CNS stimulants, and others. Atypical antipsychotics are anticipated to account for the greatest market share of all of these.
According to disease category, major depressive disorder is predicted to hold the largest market share for depression medications. Bipolar I disorder, schizophrenia, and SSRI-induced bipolar disorder are further sub-segments.
Although depression medications are offered by hospital, internet, and retail pharmacies, the retail sector held the biggest market share in 2017 and is predicted to maintain this position through 2026.
Global Depression Drugs Market: Competitive Landscape
Some key players operating in the manufacturing of depression drugs are Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson, Sebela Pharmaceutical Inc., GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Allergan USA, Inc., Takeda Pharmaceutical Company Ltd, Novartis AG, Pfizer, Inc., Alkermes Plc, H. Lundbeck, Bristol Myers Squibb Co., and Teva Pharmaceutical Industries Ltd.
๐๐จ๐ง๐ญ๐๐๐ญ:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
๐๐๐จ๐ฎ๐ญ ๐ ๐๐๐ญ.๐๐
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Depression Drugs Market is Growing at CAGR of 4% to Achieve US$ 20 Billion by 2031 | Fact.MR here
News-ID: 3493709 • Views: โฆ
More Releases from Fact.MR

Well Intervention Market is Predicted to Reach US$ 17.1 Billion by 2035, Expandi โฆ
The global well intervention market is projected to increase from USD 8.7 billion in 2025 to USD 17.1 billion by 2035, with a compound annual growth rate (CAGR) of 7.0% during the forecast period. Growth is driven by the growing need for energy, along with aging oil and gas wells. Offshore rig operators are stepping up their game by investing in both light and heavy intervention services to enhance efficiencyโฆ

Assembly Robot Market Size Worth US$ 54,915.6 Million by 2035 at a CAGR Of 11.6% โฆ
The global assembly robot market is projected to rise from USD 18,325.4 million in 2025 to USD 54,915.6 million by 2035, reflecting a robust compound annual growth rate (CAGR) of 11.6% during the forecast period. This growth is fueled by advancements in artificial intelligence, machine learning, and 5G technology, which enhance robots' precision, efficiency, and safety, particularly in collaborative operations alongside human workers.
These innovations allow assembly robots to execute complexโฆ

Zonal Isolation Packers Market is Predicted to Reach US$ 4.6 Billion by 2035, Ex โฆ
The global zonal isolation packers market is projected to increase from USD 2.8 billion by 2025 to USD 4.6 billion by 2035, with a CAGR of 5.1% during the forecast period. Growth is driven by rising focus on well integrity during drilling and production, which has accelerated the use of mechanical and swellable packers.
Operators are adopting zonal isolation systems to prevent cross-zone fluid migration and ensure long-term performance. The riseโฆ

Lithium-Ion Battery Pack Market Size Expected to Reach US$ 92.8 Billion by 2035: โฆ
The global lithium-ion (Li-ion) battery pack market is poised for significant growth, with projections indicating an increase from USD 66.4 billion in 2025 to USD 92.8 billion by 2035, reflecting a compound annual growth rate (CAGR) of 3.4% during the forecast period.
This expansion is largely driven by the rising adoption of electric vehicles (EVs), advances in renewable energy storage solutions, and ongoing innovations in battery technology.
For More Insights into theโฆ
More Releases for Depression
Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing D โฆ
Ace Therapeutics released depression-related behavior tests to accelerate preclinical depression research.
New York, USA - December 24, 2024 - Ace Therapeutics, a preclinical contract research provider dedicated to offering comprehensive one-stop services, released the expansion of its research capabilities in the area of depression through the introduction of comprehensive depression-related behavior tests [https://www.acetherapeutics.com/psychiatry/depression-behavior-tests.html] in its preclinical investigation processes. This integral development aims to enhance the understanding of depressive disorders and expediteโฆ
Postpartum Depression Global Market Report 2024 - Postpartum Depression Market S โฆ
The Business Research Company recently released a comprehensive report on the Global Postpartum Depression Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The postpartum depression marketโฆ
Depression Apps Market - Tools for Resilience, Tools for Life: Depression Apps f โฆ
Newark, New Castle, USA: The "Depression Apps Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Depression Apps Market: https://www.growthplusreports.com/report/depression-apps-market/8782
This latest report researches the industry structure, sales, revenue,โฆ
Depression Apps Market - Navigating the Path to Mental Wellbeing: Harnessing the โฆ
Newark, New Castle, USA - new report, titled Depression Apps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Depression Apps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Depression Apps market. The report offers an overview of the market, whichโฆ
Depression Treatment Device Market: Information by Product Type (Light Therapies โฆ
Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As perโฆ
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, โDepression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018โ2026โ. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to driveโฆ